世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

好酸球性食道炎治療の世界市場インサイト、2029年までの予測


Global Eosinophilic Esophagitis Treatment Market Insights, Forecast to 2029

好酸球性食道炎(EoE、好酸球性食道炎とも表記される)は、アレルギー性食道炎としても知られ、白血球の一種である好酸球が関与する食道のアレルギー性炎症性疾患である。症状としては、嚥下障害、食物詰まり、嘔... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年6月16日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

好酸球性食道炎(EoE、好酸球性食道炎とも表記される)は、アレルギー性食道炎としても知られ、白血球の一種である好酸球が関与する食道のアレルギー性炎症性疾患である。症状としては、嚥下障害、食物詰まり、嘔吐、胸焼けなどがある。

好酸球性食道炎は最初に小児で報告されたが、成人にも起こる。この病態はよくわかっていないが、食物アレルギーが重要な役割を果たしている可能性がある。治療としては、既知または疑われる誘因の除去、免疫反応を抑制する薬物療法などがある。

このレポートは好酸球性食道炎治療薬市場を調査している。
市場分析と洞察世界の好酸球性食道炎治療薬市場
世界の好酸球性食道炎治療薬市場は、2023年の1億3,800万米ドルから2029年には1億9,030万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は5.5%と予測されています。
アストラゼネカ、GSK、バイエルが好酸球性食道炎治療薬の主要生産者で、合わせて市場の約80%を占めている。
北米は市場の30%以上を占める主要地域であり、次いで欧州が30%近くを占めている。

レポートの内容
好酸球性食道炎治療薬の世界市場規模を概観します。2018年~2022年の過去の市場収益データ、2023年の推定値、2029年までのCAGR予測による世界市場動向の分析。
好酸球性食道炎治療薬の主要生産者を調査し、主要地域・国の収益も掲載しています。好酸球性食道炎治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、好酸球性食道炎治療薬の収益、市場シェア、主要企業の業界ランキングに焦点を当て、2018年から2023年までのデータを掲載しています。世界の好酸球性食道炎治療薬市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。好酸球性食道炎治療薬の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。

アストラゼネカ、GSK、バイエルなど世界の主要企業の詳細な企業プロフィール
企業別
アストラゼネカ
GSK
バイエル
タイプ別
ブデソニド
フルチカゾン
用途別セグメント
病院
診療所
その他
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東、アフリカ、中南米
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートのスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な展開について高いレベルの見解を提供しています。
第2章 好酸球性食道炎治療薬の世界および地域レベルでの売上高各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介しています。
第3章:好酸球性食道炎治療薬企業の競争環境、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章: 読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの収益、発展の可能性をカバーし、タイプ別に様々な市場セグメントの分析を提供します。
第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章:北米:タイプ別、用途別、国別、セグメント別の収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。
第8章:中国:タイプ別、用途別、セグメント別収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別収益。
第11章:主要企業のプロファイルを提供し、製品の説明や仕様、好酸球性食道炎治療薬の収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章 アナリストの視点/結論


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Budesonide
1.2.3 Fluticasone
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eosinophilic Esophagitis Treatment Market Perspective (2018-2029)
2.2 Global Eosinophilic Esophagitis Treatment Growth Trends by Region
2.2.1 Eosinophilic Esophagitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eosinophilic Esophagitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eosinophilic Esophagitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Eosinophilic Esophagitis Treatment Market Dynamics
2.3.1 Eosinophilic Esophagitis Treatment Industry Trends
2.3.2 Eosinophilic Esophagitis Treatment Market Drivers
2.3.3 Eosinophilic Esophagitis Treatment Market Challenges
2.3.4 Eosinophilic Esophagitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Eosinophilic Esophagitis Treatment by Players
3.1.1 Global Eosinophilic Esophagitis Treatment Revenue by Players (2018-2023)
3.1.2 Global Eosinophilic Esophagitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eosinophilic Esophagitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Eosinophilic Esophagitis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Esophagitis Treatment Revenue in 2022
3.5 Global Key Players of Eosinophilic Esophagitis Treatment Head office and Area Served
3.6 Global Key Players of Eosinophilic Esophagitis Treatment, Product and Application
3.7 Global Key Players of Eosinophilic Esophagitis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Eosinophilic Esophagitis Treatment Breakdown Data by Type
4.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Type (2024-2029)
5 Eosinophilic Esophagitis Treatment Breakdown Data by Application
5.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eosinophilic Esophagitis Treatment Market Size (2018-2029)
6.2 North America Eosinophilic Esophagitis Treatment Market Size by Type
6.2.1 North America Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
6.2.2 North America Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
6.2.3 North America Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
6.3 North America Eosinophilic Esophagitis Treatment Market Size by Application
6.3.1 North America Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
6.3.2 North America Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
6.3.3 North America Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
6.4 North America Eosinophilic Esophagitis Treatment Market Size by Country
6.4.1 North America Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
6.4.3 North America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Eosinophilic Esophagitis Treatment Market Size (2018-2029)
7.2 Europe Eosinophilic Esophagitis Treatment Market Size by Type
7.2.1 Europe Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
7.2.2 Europe Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
7.2.3 Europe Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
7.3 Europe Eosinophilic Esophagitis Treatment Market Size by Application
7.3.1 Europe Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
7.3.2 Europe Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
7.3.3 Europe Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
7.4 Europe Eosinophilic Esophagitis Treatment Market Size by Country
7.4.1 Europe Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
7.4.3 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Eosinophilic Esophagitis Treatment Market Size (2018-2029)
8.2 China Eosinophilic Esophagitis Treatment Market Size by Type
8.2.1 China Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
8.2.2 China Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
8.2.3 China Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
8.3 China Eosinophilic Esophagitis Treatment Market Size by Application
8.3.1 China Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
8.3.2 China Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
8.3.3 China Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Eosinophilic Esophagitis Treatment Market Size (2018-2029)
9.2 Asia Eosinophilic Esophagitis Treatment Market Size by Type
9.2.1 Asia Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
9.2.2 Asia Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
9.2.3 Asia Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
9.3 Asia Eosinophilic Esophagitis Treatment Market Size by Application
9.3.1 Asia Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
9.3.2 Asia Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
9.3.3 Asia Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
9.4 Asia Eosinophilic Esophagitis Treatment Market Size by Region
9.4.1 Asia Eosinophilic Esophagitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Eosinophilic Esophagitis Treatment Market Size by Region (2018-2023)
9.4.3 Asia Eosinophilic Esophagitis Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Eosinophilic Esophagitis Treatment Introduction
11.1.4 AstraZeneca Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Eosinophilic Esophagitis Treatment Introduction
11.2.4 GSK Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.2.5 GSK Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Eosinophilic Esophagitis Treatment Introduction
11.3.4 Bayer Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.3.5 Bayer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.
Market Analysis and Insights: Global Eosinophilic Esophagitis Treatment Market
The global Eosinophilic Esophagitis Treatment market is projected to grow from US$ 138 million in 2023 to US$ 190.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.

Report Includes
This report presents an overview of global market for Eosinophilic Esophagitis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Eosinophilic Esophagitis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Eosinophilic Esophagitis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Eosinophilic Esophagitis Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Eosinophilic Esophagitis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Eosinophilic Esophagitis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, GSK and Bayer, etc.
By Company
AstraZeneca
GSK
Bayer
Segment by Type
Budesonide
Fluticasone
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Eosinophilic Esophagitis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eosinophilic Esophagitis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eosinophilic Esophagitis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Budesonide
1.2.3 Fluticasone
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eosinophilic Esophagitis Treatment Market Perspective (2018-2029)
2.2 Global Eosinophilic Esophagitis Treatment Growth Trends by Region
2.2.1 Eosinophilic Esophagitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eosinophilic Esophagitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eosinophilic Esophagitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Eosinophilic Esophagitis Treatment Market Dynamics
2.3.1 Eosinophilic Esophagitis Treatment Industry Trends
2.3.2 Eosinophilic Esophagitis Treatment Market Drivers
2.3.3 Eosinophilic Esophagitis Treatment Market Challenges
2.3.4 Eosinophilic Esophagitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Eosinophilic Esophagitis Treatment by Players
3.1.1 Global Eosinophilic Esophagitis Treatment Revenue by Players (2018-2023)
3.1.2 Global Eosinophilic Esophagitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eosinophilic Esophagitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Eosinophilic Esophagitis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Esophagitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Esophagitis Treatment Revenue in 2022
3.5 Global Key Players of Eosinophilic Esophagitis Treatment Head office and Area Served
3.6 Global Key Players of Eosinophilic Esophagitis Treatment, Product and Application
3.7 Global Key Players of Eosinophilic Esophagitis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Eosinophilic Esophagitis Treatment Breakdown Data by Type
4.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Type (2024-2029)
5 Eosinophilic Esophagitis Treatment Breakdown Data by Application
5.1 Global Eosinophilic Esophagitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eosinophilic Esophagitis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eosinophilic Esophagitis Treatment Market Size (2018-2029)
6.2 North America Eosinophilic Esophagitis Treatment Market Size by Type
6.2.1 North America Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
6.2.2 North America Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
6.2.3 North America Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
6.3 North America Eosinophilic Esophagitis Treatment Market Size by Application
6.3.1 North America Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
6.3.2 North America Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
6.3.3 North America Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
6.4 North America Eosinophilic Esophagitis Treatment Market Size by Country
6.4.1 North America Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
6.4.3 North America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Eosinophilic Esophagitis Treatment Market Size (2018-2029)
7.2 Europe Eosinophilic Esophagitis Treatment Market Size by Type
7.2.1 Europe Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
7.2.2 Europe Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
7.2.3 Europe Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
7.3 Europe Eosinophilic Esophagitis Treatment Market Size by Application
7.3.1 Europe Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
7.3.2 Europe Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
7.3.3 Europe Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
7.4 Europe Eosinophilic Esophagitis Treatment Market Size by Country
7.4.1 Europe Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
7.4.3 Europe Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Eosinophilic Esophagitis Treatment Market Size (2018-2029)
8.2 China Eosinophilic Esophagitis Treatment Market Size by Type
8.2.1 China Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
8.2.2 China Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
8.2.3 China Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
8.3 China Eosinophilic Esophagitis Treatment Market Size by Application
8.3.1 China Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
8.3.2 China Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
8.3.3 China Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Eosinophilic Esophagitis Treatment Market Size (2018-2029)
9.2 Asia Eosinophilic Esophagitis Treatment Market Size by Type
9.2.1 Asia Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
9.2.2 Asia Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
9.2.3 Asia Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
9.3 Asia Eosinophilic Esophagitis Treatment Market Size by Application
9.3.1 Asia Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
9.3.2 Asia Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
9.3.3 Asia Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
9.4 Asia Eosinophilic Esophagitis Treatment Market Size by Region
9.4.1 Asia Eosinophilic Esophagitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Eosinophilic Esophagitis Treatment Market Size by Region (2018-2023)
9.4.3 Asia Eosinophilic Esophagitis Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Eosinophilic Esophagitis Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Eosinophilic Esophagitis Treatment Introduction
11.1.4 AstraZeneca Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Eosinophilic Esophagitis Treatment Introduction
11.2.4 GSK Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.2.5 GSK Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Eosinophilic Esophagitis Treatment Introduction
11.3.4 Bayer Revenue in Eosinophilic Esophagitis Treatment Business (2018-2023)
11.3.5 Bayer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る